^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

CD4 positive

i
Other names: CD4, CD4 Molecule, T-Cell Surface Glycoprotein CD4, T-Cell Surface Antigen T4/Leu-3, CD4 Antigen (P55), CD4 Receptor, CD4 Antigen, CD4mut
Entrez ID:
Related biomarkers:
Associations
12ms
Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular Insights. (PubMed, Mod Pathol)
It remains uncertain if nGDTCL represents a distinct entity, and further studies are needed for better characterization. Nonetheless, nodal-based GDTCL should be distinguished from secondary nodal involvement by other extranodal GDTCL and EBV-positive T/NK-cell lymphoproliferative diseases.
Journal • IO biomarker
|
TP53 (Tumor protein P53) • CD8 (cluster of differentiation 8) • CCR4 (C-C Motif Chemokine Receptor 4) • CD4 (CD4 Molecule) • NCAM1 (Neural cell adhesion molecule 1) • TBX21 (T-Box Transcription Factor 21) • GATA3 (GATA binding protein 3)
|
TP53 mutation • ATM mutation • CD8 positive • CD4 positive
1year
The mechanism of tea tree oil regulating the damage of hydrogen sulfide to spleen and intestine of chicken. (PubMed, Poult Sci)
Compared with CON, TTO treatment alleviated serum biochemical disorders and intestinal damage caused by H2S exposure and restored them to normal (P > 0.05). In conclusion, TTO can improve spleen and intestinal function and reduce the effects of H2S on growth performance and health of chickens.
Journal
|
CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • TNFA (Tumor Necrosis Factor-Alpha) • CD4 (CD4 Molecule) • CLDN1 (Claudin 1) • IL1B (Interleukin 1, beta) • TJP1 (Tight Junction Protein 1) • OCLN (Occludin)
|
CD8 positive • CD4 positive
1year
Lymphomas in 3D and 4D spaces. (PubMed, Hum Pathol)
Following incubation with nivolumab, the duration of contacts between CD4-positive T cells and CD30-positive Hodgkin-Reed-Sternberg cells was documented. The preliminary data indicate that 3D and 4D experiments in hematopathology may facilitate new insights into diagnostics, biology, and clinical applications, including the development of new lymphoma classifications.
Review • Journal
|
TNFRSF8 (TNF Receptor Superfamily Member 8) • CD4 (CD4 Molecule)
|
TNFRSF8 positive • CD4 positive
|
Opdivo (nivolumab)
1year
A Case of Progressive Multifocal Leukoencephalopathy Caused by Epcoritamab. (PubMed, Cureus)
Cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab (R-CHOP) resulted in complete molecular remission (CMR). The antibody test for JCV is recommended for patients with multiple sclerosis for an earlier diagnosis, which is not common in other diseases. We should be aware of PML through innovative therapy.
Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)
|
CD8 positive • CD4 positive
|
Rituxan (rituximab) • doxorubicin hydrochloride • cyclophosphamide • vincristine • Epkinly (epcoritamab-bysp)
1year
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder: a case report and literature review. (PubMed, Acta Dermatovenerol Alp Pannonica Adriat)
Because the disease is indolent, aggressive diagnostic tests and systemic treatments are not recommended. We present a case of PCSM-LPD in a previously healthy young man that spontaneously regressed after a biopsy.
Review • Journal
|
CD4 (CD4 Molecule)
|
CD4 positive
1year
A Case of Bullous Pemphigoid with Significant Infiltration of CD4-Positive T Cells during Treatment with Pembrolizumab, Accompanied by Pembrolizumab-Induced Multi-Organ Dysfunction. (PubMed, Diagnostics (Basel))
While it is known that drug-induced skin reactions worsen as blood eosinophil counts increase, in our case, the eosinophil count remained normal, suggesting that ICI-associated BP might have been controlled without discontinuing the ICI and through tapering of low-dose oral prednisone treatment. Few reports focus on blood eosinophil counts in BP cases or discuss CD4 and CD8 immunostaining in BP cases. Therefore, future research should explore the relationship between blood eosinophil counts, immunostaining results, and the prognosis of irAEs, including BP, in treatment courses.
Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule) • CRP (C-reactive protein)
|
CD4 positive
|
Keytruda (pembrolizumab) • prednisone
1year
ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer. (PubMed, Neoplasia)
In addition, androgen receptor (AR) was shown to be regulated with ELAVL1, and knocking down AR could also affect the expression of PD-L1. Therefore, ELAVL1 can directly or indirectly regulate the expression of PD-L1, thereby affecting the infiltration of CD4-positive T cells in PCa and ultimately leading to immune suppression.
Journal • PD(L)-1 Biomarker • IO biomarker
|
AR (Androgen receptor) • CD4 (CD4 Molecule) • ELAVL1 (ELAV Like RNA Binding Protein 1)
|
PD-L1 expression • ELAVL1 expression • CD4 positive
1year
Impact of positive CD4 cells on event-free survival in follicular lymphoma patients. (PubMed, Cancer Med)
This study demonstrated that higher expression of positive CD4 cells predicts lower risk of early failure in follicular lymphoma, and combination analysis of CD4 and FLIPI could better predict disease relapse and survival outcome.
Journal
|
CD4 (CD4 Molecule)
|
CD4 positive
1year
Clinicopathologic and prognostic characteristics of tumor budding-like in giant cell tumor of bone. (PubMed, Cancer)
The current data support the assessment of TBL structures as a reliable prognostic tool in GCTB, potentially aiding in the development of personalized treatment strategies for patients.
Journal
|
PD-L1 (Programmed death ligand 1) • CD20 (Membrane Spanning 4-Domains A1) • CD8 (cluster of differentiation 8) • PD-1 (Programmed cell death 1) • CD4 (CD4 Molecule) • FOXP3 (Forkhead Box P3)
|
CD20 positive • CD8 positive • CD4 positive
|
Prolia (denosumab)
over1year
Construction of Switch Modules for CAR-T Cell Treatment Using a Site-Specific Conjugation System. (PubMed, Bioconjug Chem)
Additionally, we obtained the purified CD8+ T cells by optimizing a shorter version of the CD8-binding aptamer to generate anti-FITC CD8-CAR-T cells, which combined with the CD4-FITC-ST switch module (anti-CD4) to eliminate the CD4-positive tumor cells in vitro and in vivo. Overall, we established a novel safety switch module by site-specific conjugation to enhance the antitumor function of universal CAR-T cells, thereby expanding the application scope of CAR-T therapy and improving its safety and efficacy.
Journal • CAR T-Cell Therapy
|
CD8 (cluster of differentiation 8)
|
PD-L1 expression • HER-2 expression • CD19 expression • CD4 positive
over1year
Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified. (PubMed, J Clin Exp Hematop)
However, ascites did not improve when treated with micafungin for Candida peritonitis. PTCL-NOS, chemotherapy, sepsis, and prednisone might have led to immunodeficiency and reactivation of EBV, which might be one of the pathophysiologies for developing ENKTL. Our case indicates that measuring EBV-DNA in the blood is a simple and prompt examination to detect complications of EBV-associated lymphoma.
Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule) • NCAM1 (Neural cell adhesion molecule 1) • CD5 (CD5 Molecule)
|
CD8 positive • CD4 positive
almost2years
Clinical effect of laparoscopic radical resection of colorectal cancer based on propensity score matching. (PubMed, World J Gastrointest Surg)
Laparoscopic radical resection of CRC has significant benefits, such as reducing postoperative pain and postoperative inflammatory response, avoiding excessive immune inhibition, and contributing to postoperative recovery.
Journal
|
CD8 (cluster of differentiation 8) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CD4 (CD4 Molecule) • CRP (C-reactive protein)
|
CD8 positive • CD4 positive